Clinical Trial Update: Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating ferric carboxymaltose (Ferinject) for anemia in patients awaiting pancreatoduodenectomy (pancreatic cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Pancreatic Cancer

Drugs mentioned

• Ferinject (ferric carboxymaltose)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Pancreatic Cancer, Anemia | Phase 2 | Status: COMPLETED